Bet

Israel, on the other hand, is gearing up for large scale serology tests in order to gauge the proportion of population which has developed antibodies against the novel coronavirus. Israel, whose aggressive response to the coronavirus has held its fatality rate to a fraction of those of the United States and other hard-hit nations, is readying a nationwide serological test of 100,000 citizens. Moshe Bar-Siman-Tov, director-general of Israel’s Health Ministry, said that if antibody tests show a sizable portion of the population has developed antibodies, that could mean Israel is on its way to “herd immunity” and would be well equipped to withstand further outbreaks. Meanwhile, studies have estimated the percentage of Israelis with antibodies range widely, from less than 1% to upward of 10%. … [Read more...] about In-Depth: Is Herd Immunity our best bet in the fight against coronavirus?

'Upside momentum in Nifty seen only above 9,200, bet on these 3 stocks for double-digit returns'Story in a chart: 'Cup & Handle' pattern in Motherson Sumi suggests buying opportunity'Expect markets to be volatile amid uncertain global sentiment; these 3 stocks can give double-digit returns' … [Read more...] about Story in a chart: Cup & Handle pattern suggests buying opportunity in D-Mart

Benchmark Index failed to hold its gains above 50 DMA, as Nifty consolidated in a tight range of 9,200-8,800 throughout the last week. The index has formed a bearish candlestick pattern on the weekly time frame suggesting selling pressure on the higher side. Important support is in the region of 8,750-8,650 levels which is a prior swing low. Currently, daily average true range, ATR 10 SMA is around 200 and it is been observed historically that 150-200 is a range of relative lower ATR and supports consolidation indicating a higher probability of sideways movement. Upside momentum will come only above 9,200. … [Read more...] about ‘Upside momentum in Nifty seen only above 9,200, bet on these 3 stocks for double-digit returns’

"Markets have closed on a positive note, after a volatile day of trade, in anticipation of GDP data due out later today. Global cues also were negative, following heightened US-China diplomatic issues, which offset stimulus news and economies opening up," Vinod Nair- Head of Research at Geojit Financial Services said. … [Read more...] about Taking Stock: Volatile Friday! Nifty reclaims 9,500; Sensex rallies over 200 points

Intas Pharma has explored the IPO route earlier but put the listing plans on hold due to market conditions. It is a vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. It has set up a network of subsidiaries, under the umbrella name of Accord Healthcare to operate in global markets. … [Read more...] about Exclusive | PE firm ChrysCapital to buy out Capital International’s stake in Intas Pharmaceuticals